Elena R. Zakharochkina, Marina I. Glukhova, Svetlana B. Lisovskaya, Konstantin V. Cherashev, Natalia V. Chukreeva

Abstract

This study aimed at updating important changes in the state regulation of medicine provision for high-cost nosologies in Russia. As a result, it was found that the regulatory framework for expensive nosologies has improved in the context of serious discussions among various pharmaceutical market regulators, medicine circulation entities, and nonprofit public organizations. Further federalization of the expenses for the medicine provision may be the main development direction for the segment of cost-demanding nosologies in the Russian Federation in the nearest future.